Any Pharma Consultancy Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 33.00%
- Ebitda 33.00%
- Net Worth -149.09%
- Total Assets 14.65%
About Any Pharma Consultancy
Any Pharma Consultancy Private Limited (APCPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 November 2015 (Nine years and three months 23 days old ). Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Service Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Milan Paul and Rajesh Agarwal serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U93000WB2015PTC208330
- Company No.
208330
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Nov 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Any Pharma Consultancy?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Milan Paul  | Additional Director | 29-Sep-2022 | Current |
| Rajesh Agarwal | Additional Director | 29-Sep-2022 | Current |
Financial Performance of Any Pharma Consultancy.
Any Pharma Consultancy Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 33% increase in profit. The company's net worth observed a substantial decline by a decrease of 149.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Any Pharma Consultancy?
In 2019, Any Pharma Consultancy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Singhal Suppliers Private LimitedMilan Paul is a mutual person
- Bhubaneswar Exim Private Limited
Rajesh Agarwal is a mutual person
- Sap Professional Services Private Limited
Rajesh Agarwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Any Pharma Consultancy?
Unlock and access historical data on people associated with Any Pharma Consultancy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Any Pharma Consultancy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Any Pharma Consultancy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
